Position in GOSS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$4,776,165
New position
Shares Held
361,831
first reported quarter
Ownership
5.92%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#4
of 169 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Context Capital Management, LLC holds $19,316,305 across 9 Biotechnology names. GOSS ranks #2 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
46,000 | $14,540,140 | |
| 2 | GOSS |
Gossamer Bio, Inc.
This page
|
361,831 | $4,776,165 | |
| 3 | MLEC |
Moolec Science SA
|
32,653 | $0 | |
| 4 | TVGN |
Tevogen Inc.
|
97,250 | $0 | |
| 5 | VRXA |
Veraxa Biotech AG - Post de-SPAC
|
100,000 | $0 | |
| 6 | CDIO |
Cardio Diagnostics Holdings, Inc.
|
81,500 | $0 | |
| 7 | APLM |
Apollomics Inc.
|
298,500 | $0 | |
| 8 | SLXN |
Silexion Therapeutics Corp
|
51,183 | $0 |
All Filings in GOSS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,776,165 | 28,946,459 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||